Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
22.97
-0.16 (-0.69%)
Aug 7, 2025, 4:00 PM - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 71 individual holdings. The top holdings are Boston Scientific stock at 5.61%, Alnylam Pharmaceuticals at 5.12%, Fidelity Securities Lending Cash Central Fund at 4.78%, argenx SE at 3.94%, and Veeva Systems at 3.64%.
Total Holdings
71
Top 10 Percentage
39.12%
Asset Class
Equity
ETF Category
Health
Assets
53.04M
PE Ratio
42.27
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BSX | Boston Scientific Corporation | 5.61% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.12% |
| 3 | n/a | Fidelity Securities Lending Cash Central Fund | 4.78% |
| 4 | ARGX | argenx SE | 3.94% |
| 5 | VEEV | Veeva Systems Inc. | 3.64% |
| 6 | DHR | Danaher Corporation | 3.50% |
| 7 | EBR: UCB | UCB SA | 3.23% |
| 8 | PODD | Insulet Corporation | 3.22% |
| 9 | LEGN | Legend Biotech Corporation | 3.12% |
| 10 | WAY | Waystar Holding Corp. | 2.97% |
| 11 | ISRG | Intuitive Surgical, Inc. | 2.92% |
| 12 | PEN | Penumbra, Inc. | 2.87% |
| 13 | EXAS | Exact Sciences Corporation | 2.80% |
| 14 | MASI | Masimo Corporation | 2.66% |
| 15 | EW | Edwards Lifesciences Corporation | 2.59% |
| 16 | SYK | Stryker Corporation | 2.52% |
| 17 | EPA: DIM | Sartorius Stedim Biotech S.A. | 1.95% |
| 18 | LLY | Eli Lilly and Company | 1.88% |
| 19 | MRUS | Merus N.V. | 1.80% |
| 20 | RMD | ResMed Inc. | 1.76% |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | 1.74% |
| 22 | ZLAB | Zai Lab Limited | 1.74% |
| 23 | DXCM | DexCom, Inc. | 1.73% |
| 24 | TMO | Thermo Fisher Scientific Inc. | 1.71% |
| 25 | SWX: LONN | Lonza Group AG | 1.49% |
As of Aug 5, 2025